
558-ATF6α: A Driver of Liver Cancer
This research identifies the protein ATF6α as a primary driver of hepatocellular carcinoma (HCC) by coordinating metabolic changes and immune system suppression. While typically part of the adaptive response to cellular stress, chronic ATF6α activation in the liver represses the enzyme FBP1, leading to a glucose-depleted environment and the accumulation of lactate. This metabolic shift exhausts anti-tumor T cells and creates an immunosuppressive landscape that facilitates cancer progression. Experimental evidence shows that inhibiting this pathway using antisense oligonucleotides or restoring…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.